Regulation of p53 expression to overcome cisplatin rsistance
Regulation of p53 expression to overcome cisplatin rsistance
批准号:
09671479
负责人:
TSUCHIYA Hiroyuki
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
P53抑癌基因产物是细胞对DNA损伤反应的重要参与者。这种反应导致Gl细胞周期停滞或通过细胞凋亡而死亡。因此,P53的状态是可以预期的。以影响细胞对DNA损伤细胞毒剂的反应。本研究旨在探讨将野生型p53基因导入人骨肉瘤细胞是否能改变细胞生长速度,增强顺铂的细胞毒作用和咖啡因的协同抗肿瘤作用。以三株人骨肉瘤细胞株OST(野生型P53等位基因)、Saos2(P53等位基因缺失)和HOS(突变型P53等位基因)为研究对象。用脂质体转染法将野生型p53表达载体分别导入骨肉瘤细胞系。与亲本细胞相比,SAOS2/P53和HOS/P53细胞的生长速度明显降低。Wst-1法检测顺铂和SY…对细胞的杀伤作用咖啡因的抗肿瘤作用更强,表明在1C50中,Saos2/P53细胞对顺铂的敏感性是Saos2细胞的两倍。咖啡因对Saos2/P53细胞株的协同抗肿瘤作用也增强。另外两个转基因细胞与它们各自的亲本细胞没有显著差异。此外,用TUNEL法分析了单独用顺铂或用顺铂加咖啡因处理的Saos2细胞和Saos2/P53细胞的凋亡事件,结果表明,与亲本Saos2细胞系相比,Saos2/P53细胞对单独用顺铂和顺铂加咖啡因的敏感性最高。OST/P53和HOS/P53细胞对单独的顺铂或顺铂加咖啡因的敏感性没有明显增加。这些结果表明,在P53基因缺失的人骨肉瘤细胞系中导入野生型P53基因,可增强顺铂的细胞毒作用和咖啡因的协同抗肿瘤作用,提示利用P53基因对P53基因异常的人骨肉瘤进行基因治疗的可能性。较少
英文摘要
The p53 tumor suppressor gene product is an important participant in the cellular response to DNA damage. This response results in either Gl cell cycle arrest or cell death by apoptosis. Therefore, the status of p53 can be expected. to affect the cellular response to DNA-damaging cytotoxic agents. The present study was performed to investigate whether introduction of the wild-type p53 gene into human osteosarcoma cells could change growth rates and enhance the cytocidal effect of cisplatin and the synergistic antitumor effect of caffeine. Three human osteosarcoma cell lines, OST (wild p53 alleles) , Saos2 (both p53 alleles deleted) , and HOS, (both mutant p53 alleles) were used. Wild-type p53 expression plasmid was transfected into each of the osteosarcoma cell lines by using the lipofection method. The transfected cells, Saos2/p53 and HOS/p53, showed a reduction in growth rate compared with the parent cells. WST-1 assay, performed to assess the cytocidal effect of cisplatin and the sy … More nergistic antitumor effect of caffeine, showed that Saos2/p53 cells were twice as sensitive to cisplatin alone in 1C50 than were Saos2 cells. The synergistic antitumor effect of caffeine also enhanced in the Saos2/p53 cell line. The other two transfected cells revealed no significant differences from their respective parent cells. Furthermore, TUNEL assay used to analyze apoptotic events in Saos2 cells and Saos2/p53 cells that were treated either with cisplatin alone or with cisplatin and caffeine revealed that compared with the parent Saos2 cell line, Saos2/p53 become most sensitive to cisplatin alone and to cisplatin with caffeine. OST/p53 and HOS/p53 cell lines did not show any significant increase in sensitivity to either cisplatin alone or to cisplatin with caffeine. These results demonstrate that the cytocidal effect of cisplatin and the synergistic antitumor effects of caffeine are enhanced by introduction of the wild-type p53 gene in a human osteosarcoma cell line with deleted p53 alleles, indicating the possibility of gene therapy using the p53 gene for human osteosarcomas with abnormal p53 status. Less
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
H.Tsuchiya: "Classification in terms of expression of p53 in cisplatin enhancement of caffeine as a biochemical modulator on human osteosarcoma cell lines." Transaction books,9th international symposium on limb salvage,New York. 141 (1997)
H.Tsuchiya:“根据顺铂增强咖啡因作为人骨肉瘤细胞系生化调节剂中 p53 表达的分类。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
土屋弘行: "ヒト骨肉腫細胞株におけるp53蛋白を標的としたcaffeineによるCDDP増強効果治療." 日本癌治療学会誌. 31(8). 712 (1996)
Hiroyuki Tsuchiya:“咖啡因针对人骨肉瘤细胞系中的 p53 蛋白增强 CDDP 治疗效果。”日本癌症治疗学会杂志 31(8)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
土屋弘行: "骨肉腫に対するカフェイン併用化学療法の分子生物学的検討-カフェインによるシスプラチン増強効果機序におけるp53蛋白の役割." 臨床整形外科. 32. 31-37 (1997)
Hiroyuki Tsuchiya:“骨肉瘤咖啡因联合化疗的分子生物学研究 - p53 蛋白在咖啡因顺铂增强作用机制中的作用。”临床骨科。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
土屋弘行: "野生型p53発現骨肉腫細胞株におけるcaffeineによるcisplatin増強効果機序の検討." 日本整形外科学会雑誌. 70(6). S997 (1996)
Hiroyuki Tsuchiya:“在表达野生型 p53 的骨肉瘤细胞系中研究咖啡因增强顺铂的机制。”日本骨科学会杂志 70(6)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
土屋弘行: "野生型p53発現ヒト骨肉腫細胞のにおけるcisplatin感受性の差異によるcaffeineのcisplatin増強効果の有無に関する検討." 日本整形外科学会雑誌. 70(8). S1212 (1996)
Hiroyuki Tsuchiya:“根据表达野生型 p53 的人骨肉瘤细胞的顺铂敏感性差异来检查咖啡因是否存在顺铂增强作用。”日本骨科学会杂志 70(8)。 )
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
Regulation of liver cancer stem cells by a lncRNA
-
批准号:19K08469
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2019
-
负责人:TSUCHIYA Hiroyuki
-
依托单位:
cryoimmunotherapy for malignant bone tumors
-
批准号:24650631
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2012
-
负责人:TSUCHIYA Hiroyuki
-
依托单位:
Treatment strategy and analysis of progression mechanism of musculoskeletal tumors using fluorescent imaging
-
批准号:23390360
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.07万
-
财政年份:2011
-
负责人:TSUCHIYA Hiroyuki
-
依托单位:
Investigation of the mechanisms of hepatic insul in sensitization by retinoi cacid.
-
批准号:23790819
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.66万
-
财政年份:2011
-
负责人:TSUCHIYA Hiroyuki
-
依托单位:
Investigation of the effect of retinoids on hepatic iron overload in a mouse NAFLD model.
-
批准号:21790666
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.75万
-
财政年份:2009
-
负责人:TSUCHIYA Hiroyuki
-
依托单位:
Fluorescent in vivo imaging of bone and soft tissue tumor -primary, metastasis and therapy-
-
批准号:20390396
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.07万
-
财政年份:2008
-
负责人:TSUCHIYA Hiroyuki
-
依托单位:
Comprehensive analysis of neogenin signaling factors in liver carcinogenesis.
-
批准号:19790484
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.42万
-
财政年份:2007
-
负责人:TSUCHIYA Hiroyuki
-
依托单位:
Research of the chemotherapy for osteosarcoma with the liposome with amphipathic polyethylene glycol(PEG) encapsulating anticancer agent or caffeine.
-
批准号:16591480
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2004
-
负责人:TSUCHIYA Hiroyuki
-
依托单位:
Acceleration of distraction osteogenesis with recombinant human bone morphogenetic protein-2 transfected into normal mesenchymal cell.
-
批准号:14571365
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:TSUCHIYA Hiroyuki
-
依托单位:
Overcoming cisplatin resistance through p53 gene using caffeine in osteosarcoma
-
批准号:11671426
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:TSUCHIYA Hiroyuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
HCN4在心房颤动肺静脉电位形成中作用的研究
-
批准号:81000082
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:王新华
-
依托单位:
肾癌干细胞的实验研究
-
批准号:81041065
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:赵升田
-
依托单位:
结外NK/T细胞淋巴瘤-鼻型异常MicroRNA表达及作用机制研究
-
批准号:81071944
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2010
-
负责人:李挺
-
依托单位:
聚乙二醇修饰的树状分子聚合物纳米基因载体在单基因缺陷所致的高脂血症的基因治疗研究中的应用
-
批准号:30971241
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2009
-
负责人:祁荣
-
依托单位:
癌干细胞形成过程中microRNA的表达及其功能研究
-
批准号:30971625
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2009
-
负责人:陈良标
-
依托单位:
H2AX、STAT1蛋白表达调控体内外食管癌细胞放射敏感性的研究
-
批准号:30870743
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:祝淑钗
-
依托单位:
超声微泡介导基因转染过程适宜空化效果的研究
-
批准号:30400419
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2004
-
负责人:修建成
-
依托单位: